Join
Live feed
·
INSIDERFilingvia Quantisnow
Werewolf Therapeutics Inc. logo

Director Evnin Luke sold $76,363 worth of shares (171,049 units at $0.45) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HOWL· Werewolf Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HOWL (Werewolf Therapeutics Inc.) and more on Quantisnow.